Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Osmotica Pharmaceuticals plc | a2240393zex-5_1.htm |
| EX-1.1 - EX-1.1 - Osmotica Pharmaceuticals plc | a2240393zex-1_1.htm |
| S-1/A - S-1/A - Osmotica Pharmaceuticals plc | a2240393zs-1a.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
Osmotica
Pharmaceuticals plc
Dublin, Ireland
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-235661) of our report dated March 27, 2019 (except for Note 1, as to which the date is December 20, 2019), relating to the consolidated financial statements of Osmotica Pharmaceuticals plc, which is incorporated by reference in that Prospectus.
We also consent to the reference to us under the caption "Experts" in the Prospectus.
/s/
BDO USA, LLP
Woodbridge, New Jersey
January 3, 2020
Consent of Independent Registered Public Accounting Firm